Datasheet PCL CAPA
Datasheet PCL CAPA
CAPA® 6100, 6106S, 6109S, 6250, 6400, 6406, 6430, 6500, 6500C,
6501, 6501S, 6502S, 6503, 6505, 6506, 6506S, 6800, and 6806
Material Safety Data Sheet
2. Composition/Information on Ingredients
INGREDIENTS FORMULA WT. PERCENT CAS #
2Oxepanone homopolymer (C6H10O2)x > 99 24980414
3. Hazards Identification
Emergency Overview: Under normal use conditions, this material is considered to present
minimal human health and environmental hazards.
3.1 Route of Entry: Inhalation: Yes Skin: Yes Ingestion: Yes
3.2 Potential Effects of exposure:
Inhalation: Dust particles may require cleaning of nasal passages.
Eyes: Mechanical irritation from particulates generated by product.
Skin contact: Decomposition gases may be irritating to the skin.
Ingestion: Minimal hazard expected in normal industrial use.
®
4. FirstAid Measures
General Recommendations: No specific treatment is necessary.
4.1 Inhalation:
• Clear nasal passages of dust and particulates.
• If exposed to excessive levels of decomposition products, remove to fresh air and get
medical attention if cough or other symptoms develop.
Eyes:
• Hold eyelids apart and flush eyes with plenty of water for at least 15 minutes.
• Get medical attention if symptoms develop.
Skin:
• Remove contaminated clothing.
• Wash skin with soap and water. Get medical attention if symptoms develop.
• Molten polymer can burn skin.
Ingestion: If subject is completely conscious, rinse mouth and administer fresh water.
4.2 Medical Treatment/Notes to Physician: None.
5. FireFighting Measures
5.1 Flash point:
• CAPA® 6100, 6106S, 6109S, 6250, 6400 (640), 6406 (646), 6430, 6500 (650), 6500C (651),
6501, 6501S, 6502S, 65003 6505 (655), 6506 (656), 6506S: 527°F (275°C).
• CAPA® 6800 (680) and 6806 (686): No data.
5.2 Autoignition Temperature: No data.
5.3 Flammability Limits: Combustible.
5.4 Unusual Fire and Explosion Hazards: Dust explosion possible.
5.5 Common Extinguishing Methods:
• Powder.
• Foam, AFFF.
• CO2.
• Water, water spray.
Inappropriate extinguishing means: No restriction.
5.6 Fire Fighting Procedures
Specific hazards: Formation of dangerous gas/vapors in case of decomposition (see Section 10).
Possible buildup of electrical charges which could cause a fire by electrical discharge.
Protective measures in case of intervention:
• Evacuate all nonessential personnel.
®
• Intervention only by capable personnel who are trained and aware of the hazards of the
product.
• Wear selfcontained breathing apparatus when in close proximity or in confined spaces.
Other precautions:
• If safe to do so, remove exposed containers, or cool with large quantities of water.
• As with any fire, clean and ventilate room before reentry.
Molten Solid:
• If possible dam large quantities of molten solid with sand or earth and allow to solidify.
• Place into a closed, labeled container compatible with the product.
• Place the container in a safe and isolated place.
• For disposal methods, refer to Section 13.
• Clean the spill area with large quantities of water.
6.3 Precautions for protection of the environment:
• Avoid discharges into the environment (sewers, rivers, soils, etc.) and take any measure
required by applicable federal, state and local laws.
• Immediately notify the appropriate authorities in case of significant discharge or if required by
applicable federal, state or local laws.
9.1 Appearance:
• CAPA® 6100, 6400 (640), 6430, 6500 (650), 6500C (651), 6800 (680): pellets.
• CAPA® 6106S, 6109S, 6406 (646), 6501, 6501S, 6502S, 6503, 6505 (655), 6506 (656), 6506S,
6806 (686): powder.
• CAPA® 6100, 6250: solid.
Color: White.
Odor: Odorless.
9.2 Important Health, Safety and Environmental information:
pH: Not applicable.
Change of state:
Melting point: 136140°F (5860°C).
Boiling point: Not determined.
Decomposition Temperature: 392°F (200°C).
Flash Point:
• CAPA® 6100, 6106S, 6109S, 6250, 6400 (640), 6406 (646), 6430, 6500 (650), 6501,
6501S, 6502S, 6500C (651), 6505 (655), 6506 (656), 6506S: 527°F (275°C).
• CAPA® 6800 (680) and 6806 (686): No data.
Flammability: Nonflammable.
Biotic: No data.
12.5 Potential for bioaccumulation: No data.
12.6 Other adverse effects/Comments: Ingestion of pellets by wildlife and fish may cause
satiation (fullness) or bowel constriction. Consult the Society of the Plastics Industry’s Clean
Sweep Program to assure minimal impact to the environment.
To our actual knowledge, the information contained herein is accurate as of the date of this
Perstorp Polyols, Inc.
document. However, neither Solvay Chemicals, Inc. nor any of its affiliates makes any warranty,
express or implied, or accepts any liability in connection with this information or its use. This
information is for use by technically skilled persons at their own discretion and risk and does not
relate to the use of this product in combination with any other substance or any other process.
This is not a license under any patent or other proprietary right. The user alone must finally
determine suitability of any information or material for any contemplated use, the manner of use
and whether any patents are infringed. This information gives typical properties only and is not
to be used for specification purposes. SolvayPerstorp Polyols
Chemicals, Inc. reserves the right to make
additions, deletions or modifications to the information at any time without prior notification.
Suitability of Caprolactone Resins in Medical Applications: Solvay Perstorp Polyols
Chemicals, Inc. does not claim
Perstorp Polyols
suitability of caprolactone products for any specific medical applications. Solvay Chemicals will
not knowingly sell (unless so specified in a written contractual agreement) into medical applications
involving long term contact with internal bodily fluids, cardiac prosthetic devices, critical components
Perstorp
sustaining human life, or involving human reproduction and pregnancy. In addition, Solvay Chemicals
reserves the right at any time in its sole discretion not to sell into other medical applications not
listed above.
Prior to purchasing Solvay Chemicals caprolactone products for use in any of the above medical
applications, customers will be required to sign appropriate documentation agreeing to accept full
responsibility for, and indemnify Solvay Chemicals against, any and all liability associated with the
use of such products in such medical applications.
In all instances, it is the responsibility of the medical device or pharmaceutical manufacturer to
determine that the Solvay Chemicals product is safe, lawful and technically suitable for the intend
®